This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: King's College London, Cancer Research Technology Limited, Gammadelta Therapeutics Ltd. Active years: 2023-2026.
Company Filing History:
4 out of 196 
2 out of 268 
2 out of 8 Years Active: 2023-2026
Title: Richard Woolf: Innovator in T Cell Expansion
Introduction
Richard Woolf is a notable inventor based in London, GB. He has made significant contributions to the field of immunology, particularly in the expansion of γδ T cells. With a total of 4 patents, his work has the potential to impact therapeutic approaches in cancer treatment.
Latest Patents
Woolf's latest patents include innovative methods for expanding γδ T cells from non-haematopoietic tissue sources. The first patent, titled "Expansion of γδ T cells, compositions, and methods of use thereof," provides methods for expanding these cells and outlines compositions and applications in adoptive T cell therapy. The second patent, similarly titled, also focuses on the expansion of γδ T cells and their therapeutic uses.
Career Highlights
Throughout his career, Richard Woolf has worked with prestigious institutions such as King's College London and Gammadelta Therapeutics Ltd. His research has been pivotal in advancing the understanding and application of γδ T cells in medical therapies.
Collaborations
Woolf has collaborated with esteemed colleagues, including Adrian Hayday and Oliver Nussbaumer, contributing to the advancement of immunological research.
Conclusion
Richard Woolf's innovative work in expanding γδ T cells showcases his commitment to advancing medical science. His patents and collaborations highlight his significant role in the field of immunology.